Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban management for high-risk gastrointestinal endoscopic procedures
jRCTs031180190Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of edoxaban in Atrial fibrillation (AFib) and deep vein thrombosis (DVT), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Post-procedural bleeding rate (Grade ≥3). Started Oct 2018; status: completed.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)deep vein thrombosis (DVT)
Beyond the preview
Go deeper on jRCTs031180190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180190.